| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 02/21/2008 | US20080045591 (E)-7,7-Dimethyl-1-(4-hydroxy-3-methoxyphenyl)-oct-1-ene-3,5-dione; (E)-1-(4-Hydroxy-3-methoxyphenyl)-6-methyl-hept-1-ene-3,5-dione; prophylaxis of hypersensitivity, smooth muscle disorders, spasmodic conditions, allergic conditions, inflammatory conditions and/or pain |
| 02/21/2008 | US20080045529 Use Of Thienopyrimidines |
| 02/21/2008 | US20080045527 Immunomodulating Heterocyclic Compounds |
| 02/21/2008 | US20080045522 Omega-aminoalkylamides of r-2-aryl-propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells |
| 02/21/2008 | US20080045503 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 02/21/2008 | US20080045490 Pharmaceutical Compositions |
| 02/21/2008 | US20080045473 Compositions and methods for oligonucleotide formulations |
| 02/21/2008 | US20080045455 RAGE fusion proteins, formulations, and methods of use thereof |
| 02/21/2008 | US20080045443 Compositions for Inhibiting plexin-A1-DAP12 interactions and Methods of Treating Inflammatory, Autoimmune or Bone Resorption Diseases Using the Same |
| 02/21/2008 | US20080044502 Use of an aqueous or hydroalcoholic extract of bauhinia for the preparation of a composition |
| 02/21/2008 | US20080044463 Bradykinin B2 Receptor Antagonist Peptide From Amphibian Skin |
| 02/21/2008 | US20080044453 Therapeutic Agent for Treatment of Autoimmune Diseases |
| 02/21/2008 | US20080044444 Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
| 02/21/2008 | US20080044440 Vaccine Formulated For Administration To Mucosa Of The Lungs |
| 02/21/2008 | US20080044437 Encapsidation System for Production of Recombinant Virus-Like Particles |
| 02/21/2008 | US20080044436 Method for Screening and Compositions for Treating Cancers |
| 02/21/2008 | US20080044435 Tat-Based Tolerogen Compositions and Methods of Making and Using Same |
| 02/21/2008 | US20080044424 Antagonists of protease activated receptor-1 (par1) |
| 02/21/2008 | US20080044423 Compounds |
| 02/21/2008 | US20080044421 Methods of using death receptor ligands and CD20 antibodies |
| 02/21/2008 | US20080044409 Inflammatory mediator antagonists |
| 02/21/2008 | US20080044407 Mage-a3/hpv 16 peptide vaccines for head and neck cancer |
| 02/21/2008 | US20080044405 Noble metal complex-mediated immunosuppression |
| 02/21/2008 | US20080044400 Targeted enzyme prodrug therapy |
| 02/21/2008 | US20080044392 Isolation of Stem Cell-Like Cells and Use Thereof |
| 02/21/2008 | US20080044391 Different dendritic cell subsets |
| 02/21/2008 | US20080044385 Novel Modified Galectin 8 Proteins and Use Thereof |
| 02/21/2008 | US20080044383 increasing engraftment potential of a cell, treating or alleviating a symptom of an immune disorder, tissue injury or cancer by administering to a subject, e.g. human a composition comprising the cells; CD34 and CD44 |
| 02/21/2008 | US20080044354 Compounds Containing a N-Heteroaryl Moiety Linked to Fused Ring Moieties for the Inhibition of Nad(P)H Oxidases and Platelet Activation |
| 02/21/2008 | US20080042818 Trailer tire alert system |
| 02/21/2008 | DE102006038403A1 Verwendung bestimmter chemischer Verbindungen zur Inhibierung der Peptidyl-Prolyl-cis/trans-Isomeraseaktivität von Cyclophilinen The use of certain chemical compounds for inhibition of the peptidyl-prolyl cis / trans isomerase activity of cyclophilins |
| 02/21/2008 | CA2660880A1 Treatment of inflammatory diseases |
| 02/21/2008 | CA2660836A1 Triazolotriazines as kinase inhibitors |
| 02/21/2008 | CA2660463A1 Antibodies to il-17a |
| 02/21/2008 | CA2660229A1 Administration of high potency platinum compound formulations by inhalation |
| 02/21/2008 | CA2660204A1 Nucleic acid modulation of toll-like receptor-mediated immune stimulation |
| 02/21/2008 | CA2660178A1 Promiscuous her-2/neu cd4 t cell epitopes |
| 02/21/2008 | CA2658557A1 Optimized antibodies that target cd19 |
| 02/20/2008 | EP1889911A2 An antisense oligonucleotide preparation method |
| 02/20/2008 | EP1889839A1 Bicyclic compound, production and use as HIV inhibitors |
| 02/20/2008 | EP1889838A1 Thrombopoietin mimetics |
| 02/20/2008 | EP1889639A2 Methods and compositions containing succinimide or maleimide derivatives of antineoplastic agents, for producing long lasting antineoplastic agents |
| 02/20/2008 | EP1889630A1 Vaccines |
| 02/20/2008 | EP1889623A2 Use of rhamnolipids in wound healing, treating burn shock, atherosclerosis, organ transplants, depression, schizophrenia and cosmetics |
| 02/20/2008 | EP1889065A2 Methods for diagnosis and treatment of diseases having an autoimmune and/or inflammatory component |
| 02/20/2008 | EP1888573A1 Thiazole derivatives and use thereof |
| 02/20/2008 | EP1888122A2 A method for preparing a stable immunogenic product comprising antigenic heterocomplexes of tnf alpha and a carrier protein |
| 02/20/2008 | EP1888052A2 Blockade of pin1 prevents cytokine production by activated immune cells |
| 02/20/2008 | EP1603559B1 Pharmaceutical composition for intracellular acidification with cis-urocanic acid |
| 02/20/2008 | EP1406667B1 Methods for increasing in vivo efficacy of oligonucleotides and inhibiting inflammation in mammals |
| 02/20/2008 | EP1383747B1 Fused pyrimidines as antagonists of the corticotropin releasing factor (crf) |
| 02/20/2008 | EP1326638B9 Vaccines against cancers |
| 02/20/2008 | EP1289968B1 Cyclic urea compounds and preparation thereof |
| 02/20/2008 | EP1289548B1 Immune system stimulating means |
| 02/20/2008 | EP1225915B1 Use of anti-il-2 polyclonal antibodies for the treatment of insulin-dependent diabetes mellitus and lupus erythematosus |
| 02/20/2008 | EP1218028B1 Dendritic cells activated in the presence of glucocorticoid hormones are capable of suppressing antigenspecific t cell responses |
| 02/20/2008 | EP1131290B1 Piperidine ccr-3 receptor antagonists |
| 02/20/2008 | EP0938315B9 Immune response modifier compounds for treatment of th2 mediated and related diseases |
| 02/20/2008 | EP0918872B1 A method for inhibiting immunoglobulin-induced toxicity resulting from the use of immunoglobulins in therapy and in vivo diagnosis |
| 02/20/2008 | EP0768890B1 Methods for modulating t cell responses by manipulating a common cytokine receptor gamma chain |
| 02/20/2008 | EP0689551B1 Immunogenic chimeras comprising nucleic acid sequences encoding endoplasmic reticulum signal sequence peptides and at least one other peptide, and their uses in vaccines and disease treatments |
| 02/20/2008 | CN101128484A Compositions and methods relating to anti IGF-1 receptor antibodies |
| 02/20/2008 | CN101128451A Derivatives of n-[(4,5-diphenyl-2-thienyl)methyl]amine, their preparations and therapeutic application |
| 02/20/2008 | CN101128217A Use of a modified proxvirus for the rapid induction of immunity against a poxvirus or other infectious agents |
| 02/20/2008 | CN101128129A Nutritional composition with probiotics |
| 02/20/2008 | CN101128122A Fermented tea beverage and tea beverage |
| 02/20/2008 | CN101126076A TGF-beta induced adjustment T cell and its forming method and application |
| 02/20/2008 | CN101125836A Costene lactone derivative and medical use thereof |
| 02/20/2008 | CN101125153A Acanthopanax root granule and its preparation method |
| 02/20/2008 | CN101125151A Bacteroides signal molecule microecological preparation and its preparation method |
| 02/20/2008 | CN101124948A Traditional Chinese medicinal composition for raising southern American white prawn |
| 02/20/2008 | CN101124945A Special-purpose traditional Chinese medicinal composition for fresh water fish infectious diseases |
| 02/20/2008 | CN100369933C Preparation and use of monoclonal antibody against human GL50 |
| 02/20/2008 | CN100369919C Tricyclic protein kinase inhibitors |
| 02/20/2008 | CN100369903C Five-membered-ring compound |
| 02/20/2008 | CN100369898C Nicotinamide derivates useful as p38 inhibitors |
| 02/20/2008 | CN100369894C Nitric oxide synthase inhibitor phosphate salt |
| 02/20/2008 | CN100369891C HIF hydroxylase inhibitors |
| 02/20/2008 | CN100369609C Compound dired Chinese forest frog oil capsule and its preparation |
| 02/20/2008 | CN100369608C Suspension spray for treating allergic rhinitis and its preparing method |
| 02/19/2008 | US7332631 Fc receptor modulating compounds and compositions |
| 02/19/2008 | US7332517 1-(1H-indol-3-ylmethyl)-3-(4-nitrophenyl)-5-[2-(4-phenyl-1H-imidazol-2-yl)ethyl]-2thioxo-4imidazolidinone; somastatin receptor affinity; acromegaly, hypophyseal adenomas, endocrine gastroenteropancreatic tumors, as carcinoid syndrome and gastrointestinal bleeding |
| 02/19/2008 | US7332508 heterocyclic amines such as 1-Cyclopentyl-4-{2-[5-(4-methanesulfonylphenyl)[1,2,4]oxadiazol-3-yl]ethyl}piperidine and salts, used as histamine-H3 receptor antagonists for treatment of nervous system, cardiovascular , respiratory system, gastrointestinal system and endocrinological system disorders |
| 02/19/2008 | US7332507 Cholinergic ligands at the nicotinic acetylcholine receptors and modulators of the monoamine receptors and transporters; treating pain, neurodegeneration, inflammation, and drug or alcohol withdrawal symptoms; 3-benzimidazole, indole or triazole substituted |
| 02/19/2008 | US7332498 N-(3-amino-propyl)-N-[1-(3-benzyl-4-oxo-3,4-dihydro-pyrido[2,3-d]pyrimidin-2-yl)-2-methyl-propyl]-4-methyl-benzamide; kinesin spindle protein inhibitor; cell division, mitosis phase arrest; antiproliferative and antiinflammation agent, hyperplasias, restenosis, cardiac hypertrophy, autoimmune disorders |
| 02/19/2008 | US7332497 Pyrazolopyrimidines as therapeutic agents |
| 02/19/2008 | US7332496 Methods of using sodium channel blockers |
| 02/19/2008 | US7332486 9-(4-carboxyphenyl)-6-cyclopropylamino-2-trifluoromethylpurine; side effect reduction; cognition activator, antidepressants, neuroleptic agent, schizophrenia, Alzheimer's disease, schizophrenia, Parkinson's, Huntington's, Pick's, Creutzfeld-Jakob, cardiovascular diseases, HIV |
| 02/19/2008 | US7332484 2,4-pyrimidinediamine compounds and their uses |
| 02/19/2008 | US7332481 Thrombopoietin mimetics |
| 02/19/2008 | US7332478 Antitumoral composition based on immunogenic polypeptide with modified cell location |
| 02/19/2008 | US7332472 Isomeric mixture of a cyclosporine analogue modified at the 1-amino acid residue with a 1,3-diene substituent; antiinflammatory agents; autoimmune disease; side effect reduction; reduced toxicity |
| 02/19/2008 | US7332185 Component I selected from alpha acids and beta acids and component II selected from alpha acids, beta acids, essential oils, fats and waxes; specific inhibition of cyclooxygenase-2 with little effect on cyclooxygenase-1 |
| 02/19/2008 | US7332163 Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as therapeutics |
| 02/19/2008 | US7332157 Methods for human allografting |
| 02/19/2008 | CA2468435C Process for the production of an immunosuppressant |
| 02/19/2008 | CA2328927C Benzamide derivatives for the treatment of diseases mediated by cytokines |
| 02/19/2008 | CA2316310C Gamma-glutamyl and beta-aspartyl containing immunomodulator compounds and methods therewith |
| 02/19/2008 | CA2273848C Mycobacterium vaccae for down-regulation of the th2 activity of the immune system |
| 02/19/2008 | CA2273240C Compositions and methods for treating or preventing inflammatory diseases |